Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

PSORIATIC ARTHRITIS

  • You have access
    Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis
    Barry J. Sheane, Arane Thavaneswaran, Dafna D. Gladman and Vinod Chandran
    The Journal of Rheumatology September 1 2016, 43 (9) 1718-1723; DOI: https://doi.org/10.3899/jrheum.160111
  • You have access
    A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial
    Maurizio Cutolo, Gary E. Myerson, Roy M. Fleischmann, Frédéric Lioté, Federico Díaz-González, Filip Van den Bosch, Helena Marzo-Ortega, Eugen Feist, Kamal Shah, ChiaChi Hu, Randall M. Stevens and Airi Poder
    The Journal of Rheumatology September 1 2016, 43 (9) 1724-1734; DOI: https://doi.org/10.3899/jrheum.151376
  • You have access
    The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study
    Shay Brikman, Victoria Furer, Jonathan Wollman, Sara Borok, Hagit Matz, Arik Polachek, Ofir Elalouf, Amir Sharabi, Ilana Kaufman, Daphna Paran and Ori Elkayam
    The Journal of Rheumatology September 1 2016, 43 (9) 1749-1754; DOI: https://doi.org/10.3899/jrheum.151491
  • You have access
    Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study
    Zahi Touma, Arane Thavaneswaran, Vinod Chandran, Fawnda Pellett, Richard J. Cook and Dafna D. Gladman
    The Journal of Rheumatology June 1 2016, 43 (6) 1057-1062; DOI: https://doi.org/10.3899/jrheum.150466
  • You have access
    Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials
    Bernard Combe, Frank Behrens, Neil McHugh, Fiona Brock, Urs Kerkmann, Blerina Kola and Gaia Gallo
    The Journal of Rheumatology June 1 2016, 43 (6) 1063-1067; DOI: https://doi.org/10.3899/jrheum.151290
  • You have access
    Patients with Psoriatic Arthritis Fulfilling the Minimal Disease Activity Criteria Do Not Have Swollen and Tender Joints, but Have Active Skin
    Josefina Marin, María Laura Acosta Felquer, Leandro Ferreyra Garrot, Santiago Ruta, Javier Rosa and Enrique R. Soriano
    The Journal of Rheumatology May 1 2016, 43 (5) 907-910; DOI: https://doi.org/10.3899/jrheum.151101
  • You have access
    Longterm Clinical Outcomes in 420 Patients with Psoriatic Arthritis Taking Anti-tumor Necrosis Factor Drugs in Real-world Settings
    Florenzo Iannone, Simona Lopriore, Romano Bucci, Giuseppe Lopalco, Angela Chialà, Luca Cantarini and Giovanni Lapadula
    The Journal of Rheumatology May 1 2016, 43 (5) 911-917; DOI: https://doi.org/10.3899/jrheum.151042
  • You have access
    Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors
    Ennio Lubrano, Wendy J. Parsons and Fabio Massimo Perrotta
    The Journal of Rheumatology May 1 2016, 43 (5) 918-923; DOI: https://doi.org/10.3899/jrheum.151404
  • You have access
    Prologue: 2015 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
    Wolf-Henning Boehncke, Dafna D. Gladman and Philip S. Helliwell
    The Journal of Rheumatology May 1 2016, 43 (5) 949-951; DOI: https://doi.org/10.3899/jrheum.160112
  • You have access
    GRAPPA Trainees Symposium 2015: A Report from the GRAPPA 2015 Annual Meeting
    Michael Milliken, Elena Generali, Josefina Marin and Christopher T. Ritchlin
    The Journal of Rheumatology May 1 2016, 43 (5) 952-958; DOI: https://doi.org/10.3899/jrheum.160113

Pages

  • Previous
  • Next
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 49

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire